LES Research Triangle Park Chapter presents:
A New Approach to Public Private Partnerships to Solve Challenging Societal Issues
Presentation and Lunch
Tuesday, April 16, 2019: 11:30 am - 1:30pm Eastern
Finding a cure for HIV remains an elusive goal with an immense societal impact. In 2015, the University of North Carolina at Chapel Hill and GlaxoSmithKline partnered to focus on discovering a cure for HIV/AIDS through the formation of the UNC HIV Cure Center directed by Dr. David Margolis. UNC-CH and GSK co-founded a jointly owned company, Qura Therapeutics, which handles the business side of the partnership. This incredibly unique public-private partnership is redefining the traditional way of conducting research and is creating a new model to seek the breakthroughs needed to tackle an extraordinarily challenging global health issue. In October of 2018, the ViiV Healthcare Discovery Unit and GSK’s HIV Discovery Performance Unit (DPU) merged and ViiV assumed GSK roles and responsibilities as it pertains to the partnership.
This presentation will cover the case for change in establishing this center, the business structure that was set up to facilitate success and key learnings on the human side of the interactions.
Mary Napier, Director of Operations, HIV Cure Center, The University of North Carolina at Chapel Hill
Brian Johns, VP of External Discovery Sciences, ViiV Healthcare
Before Apr 9:
LES Member: $30
After Apr 9:
LES Member: $35
The RTP Chapter uses online registration for members and non-members and accepts payment by credit card. Members should login to the registration page with their LES online account.
A $5.00 cancellation fee is applied to all refunds. Cancellations are non-refundable after Apr 9. Substitutions are accepted. Contact LES at (703) 234-4058 for assistance.
Requests for ADA accommodations and special dietary needs should be submitted to the event contact listed at the top of the page.
By registering for this event, you permit LES and its chapters to use photographs of you with or without your name and for any lawful purpose, including for example such purposes as publicity, illustration, advertising, and web content.